Publications by authors named "Mitsu Onoma"

Claim this Profile
A
An orally active motilin receptor antagonist, MA-2029, inhibits motilin-induced gastrointestinal motility, increase in fundic tone, and diarrhea in conscious dogs without affecting gastric emptying.
Ken-ichi Ozaki, Mitsu Onoma, Hiroyasu Muramatsu, Hirokazu Sudo, Shoshin Yoshida

Eur J Pharmacol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of mitemcinal (GM-611), an orally active erythromycin-derived prokinetic agent, on delayed gastric emptying and postprandial glucose in a new minipig model of diabetes.
Ken-ichi Ozaki, Makoto Monnai, Mitsu Onoma, Hiroyasu Muramatsu, Kenji Yogo

J Diabetes Complications· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitemcinal (GM-611), an orally active motilin receptor agonist, improves delayed gastric emptying in a canine model of diabetic gastroparesis.
Mitsu Onoma, Ken-ichi Ozaki, Kenji Yogo, Makoto Monnai, Hiroyasu Muramatsu

Clin Exp Pharmacol Physiol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of oral mitemcinal (GM-611), erythromycin, EM-574 and cisapride on gastric emptying in conscious rhesus monkeys.
Kenji Yogo, Mitsu Onoma, Ken-Ichi Ozaki, Masao Koto, Zen Itoh

Dig Dis Sci· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral administration of MA-2029, a novel selective and competitive motilin receptor antagonist, inhibits motilin-induced intestinal contractions and visceral pain in rabbits.
Hirokazu Sudo, Shoshin Yoshida, Ken-ichi Ozaki, Hiroyasu Muramatsu, Mitsu Onoma

Eur J Pharmacol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral mitemcinal (GM-611), an erythromycin-derived prokinetic, accelerates normal and experimentally delayed gastric emptying in conscious dogs.
Mitsu Onoma, Kenji Yogo, Ken-Ichi Ozaki, Kenshi Kamei, Michitaka Akima

Clin Exp Pharmacol Physiol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of mitemcinal (GM-611), an acid-resistant nonpeptide motilin receptor agonist, on the gastrointestinal contractile activity in conscious dogs.
Ken-ichi Ozaki, Kenji Yogo, Hirokazu Sudo, Mitsu Onoma, Kenshi Kamei

Pharmacology· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis